BAFNA PHARMACEUTICALS
Back to All Ratios
|
BAFNA PHARMACEUTICALS Last 5 Year Core EBITDA Growth History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Core EBITDA Growth(%) | -4.88 | -22.93 | 39.00 | 23.66 | 644.34 |
What is the latest Core EBITDA Growth ratio of BAFNA PHARMACEUTICALS ?
| Year | Core EBITDA Growth |
|---|---|
| Mar2025 | -4.88 |
| Mar2024 | -22.93 |
| Mar2023 | 39.00 |
| Mar2022 | 23.66 |
| Mar2021 | 644.34 |
How is Core EBITDA Growth of BAFNA PHARMACEUTICALS Trending?
| Years | Core EBITDA Growth | % Change | |
|---|---|---|---|
| Mar2025 | -4.88 | Negative | |
| Mar2024 | -22.93 | Negative | |
| Mar2023 | 39 | 64.84 | |
| Mar2022 | 23.66 | -96.33 | |
| Mar2021 | 644.34 | - | |
Other Financial Ratios of BAFNA PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Growth ratio of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹343.7 Cr | 30.6% | 29.7% | 93.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 30.6% |
29.7% |
93.5% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses